Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
Palisade Bio, Inc. (Nasdaq: PALI) has announced its participation in the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group The company's CEO, J.D. Finley, and CMO, Dr. Mitch Jones, will engage in a fireside chat on Tuesday, October 15th at 4:30 PM ET.
Palisade Bio is a biopharmaceutical company dedicated to developing novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The summit will feature presentations and interactive discussions with CEOs and key management from various healthcare sectors, including biotechnology, diagnostics, medical devices, and healthcare information technology.
Interested parties can attend the virtual event by signing up for M-Vest membership. The summit promises to offer timely and engaging industry panels alongside company presentations.
Palisade Bio, Inc. (Nasdaq: PALI) ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit, presentato da Maxim Group. Il CEO dell'azienda, J.D. Finley, e il CMO, Dr. Mitch Jones, parteciperanno a un incontro informale martedì 15 ottobre alle 16:30 ET.
Palisade Bio è un'azienda biofarmaceutica dedicata allo sviluppo di terapie innovative per i pazienti affetti da malattie autoimmuni, infiammatorie e fibrotiche. Il summit presenterà relazioni e discussioni interattive con CEO e membri chiave della gestione di vari settori della sanità, inclusi biotecnologie, diagnostica, dispositivi medici e tecnologia dell'informazione sanitaria.
Le parti interessate possono partecipare all'evento virtuale registrandosi per diventare membri di M-Vest. Il summit promette di offrire tavole rotonde tempestive e coinvolgenti insieme alle presentazioni delle aziende.
Palisade Bio, Inc. (Nasdaq: PALI) ha anunciado su participación en el 2024 Maxim Healthcare Virtual Summit, presentado por Maxim Group. El CEO de la compañía, J.D. Finley, y el CMO, Dr. Mitch Jones, participarán en un chat informal el martes 15 de octubre a las 4:30 PM ET.
Palisade Bio es una compañía biofarmacéutica dedicada al desarrollo de terapias novedosas para pacientes con enfermedades autoinmunes, inflamatorias y fibróticas. El summit contará con presentaciones y discusiones interactivas con CEOs y gerentes clave de diversos sectores de la salud, incluyendo biotecnología, diagnóstico, dispositivos médicos y tecnología de la información en salud.
Las partes interesadas pueden asistir al evento virtual registrándose para la membresía de M-Vest. El summit promete ofrecer paneles de industria oportunos y atractivos junto con presentaciones de las empresas.
Palisade Bio, Inc. (Nasdaq: PALI)는 Maxim Group이 주최하는 2024 Maxim Healthcare Virtual Summit에 참여한다고 발표했습니다. 회사의 CEO인 J.D. Finley와 CMO인 Dr. Mitch Jones는 10월 15일 화요일 오후 4시 30분 ET에 대담을 진행할 예정입니다.
Palisade Bio는 자가면역질환, 염증성질환 및 섬유화질환 환자를 위한 새로운 치료법 개발에 전념하는 생명공학 회사입니다. 이번 서밋은 생명공학, 진단, 의료기기, 헬스케어 정보기술 등 다양한 헬스케어 분야의 CEO와 주요 경영진과의 발표 및 상호작용이 포함될 예정입니다.
관심 있는 분들은 M-Vest 회원 가입을 통해 가상 이벤트에 참석할 수 있습니다. 이번 서밋은 시의적절하고 매력적인 산업 패널과 기업 프레젠테이션을 제공할 것으로 기대됩니다.
Palisade Bio, Inc. (Nasdaq: PALI) a annoncé sa participation au 2024 Maxim Healthcare Virtual Summit, présenté par Maxim Group. Le PDG de l'entreprise, J.D. Finley, et le CMO, Dr. Mitch Jones, participeront à un entretien informel le mardi 15 octobre à 16h30 ET.
Palisade Bio est une entreprise biopharmaceutique dédiée au développement de nouveaux thérapeutiques pour les patients atteints de maladies auto-immunes, inflammatoires et fibrosantes. Le sommet présentera des présentations et des discussions interactives avec des PDG et des membres clés de la direction de divers secteurs de la santé, y compris la biotechnologie, le diagnostic, les dispositifs médicaux et la technologie de l'information sanitaire.
Les parties intéressées peuvent assister à l'événement virtuel en s'inscrivant à l'adhésion M-Vest. Le sommet promet d'offrir des panels sectoriels opportunes et engageants, ainsi que des présentations d'entreprises.
Palisade Bio, Inc. (Nasdaq: PALI) hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit angekündigt, der von der Maxim Group präsentiert wird. Der CEO des Unternehmens, J.D. Finley, und der CMO, Dr. Mitch Jones, werden an einem Feuergespräch am Dienstag, den 15. Oktober um 16:30 Uhr ET teilnehmen.
Palisade Bio ist ein biopharmazeutisches Unternehmen, das sich der Entwicklung neuartiger Therapeutika für Patienten mit autoimmunen, entzündlichen und fibrösen Krankheiten widmet. Der Gipfel wird Präsentationen und interaktive Diskussionen mit CEOs und leitenden Managern aus verschiedenen Gesundheitssektoren, einschließlich Biotechnologie, Diagnostik, Medizinprodukte und Gesundheitstechnologie, bieten.
Interessierte können an der virtuellen Veranstaltung teilnehmen, indem sie sich für eine M-Vest-Mitgliedschaft anmelden. Der Gipfel verspricht, zeitgemäße und ansprechende Branchendiskussionen sowie Unternehmenspräsentationen zu bieten.
- None.
- None.
– Live webcast fireside chat on Tuesday, October 15th at 4:30 PM ET
Carlsbad, CA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, CMO of Palisade Bio will participate in a fireside chat at the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on Tuesday, October 15, 2024 at 4:30 PM ET.
Maxim Senior Analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. We also plan to host several topical industry panels that promise to be timely and engaging. To attend, just sign up to become an M-Vest member and stay tuned for more updates.
Click here to reserve your seat
About Palisade Bio
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com
FAQ
When is Palisade Bio (PALI) participating in the Maxim Healthcare Virtual Summit?
Who will represent Palisade Bio (PALI) at the 2024 Maxim Healthcare Virtual Summit?
What is the focus of Palisade Bio's (PALI) drug development?
How can investors attend the 2024 Maxim Healthcare Virtual Summit featuring Palisade Bio (PALI)?
